glp-1 obesity drug news World Health Organization recommends drugs for Half of GLP-1 users ditch

For researchers tracking multiple health markers alongside weight, the GLP-1 plotter tool can help visualize progress across different parameters over time

In people with obesity, particularly in cases of rapid or marked weight reduction, the decline in lean mass may account up to 2530% of the total weight loss, contributing to the so-called sarcopenic obesity [18]

10.1016/j.biopsych.2015.02.020 [DOI] [PMC free article] [PubMed] [Google Scholar] Hamon M., Blier P

Drugs.coms medical review similarly states that there is no clear evidence that Ozempic, Wegovy, Mounjaro or Zepbound directly cause hair loss

At the same time, obesity is showing up more often across the world, and there is also more public awareness about obesity related health complications which, is pushing people toward better solutions

These data are game changing, Fatima Rodriguez, MD, MPH, FACC, FAHA, FASPC , associate professor in cardiovascular medicine and section chief of preventive cardiology at Stanford University, told Healio